Intellia Therapeutics

14 Decision Makers Β· 15 Verified Contacts & Email Format

πŸ“ Cambridge, MABiotechnologyπŸ—“ Est. 2014πŸ‘₯ 501–1000 employees

About Intellia Therapeutics

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Email Format

{first_name}.{last_name}@intelliatx.com β€” 100.0%

sarah.smith@intelliatx.com

Leadership & Decision Makers

Contact details of 14 Intellia Therapeutics decision makers

Eliana Clark

Chief Technical Officer LinkedIn
  • Work email

    e**********k@intelliatx.com

Samantha Soukamneuth

Associate Director LinkedIn
  • Work email

    s******************h@intelliatx.com

Derrick Rossi

Founder

Glenn Goddard

CFO

David Lebwohl

Chief Medical Officer

Erik Sontheimer

Co-Founder

John Leonard

President , Chief Executive Officer & Member Board of Directors

Amita Joshi

Senior Director Alliance Management

Jennifer Mound Smoter

Senior Vice President, External Affairs & Communications

Jennifer Doudna

Founder

Andy May

Founder

Luciano Marraffini

Founder

Nessan Bermingham

Founder

Rodolphe Barrangou

Founder

Team & Specialists

Contact details of 1 Intellia Therapeutics team members

Mary Margaret McKee

LinkedIn
  • Work email

    m********e@intelliatx.com

General Emails

General company emails, e.g. customer support lines

    medicalinformation@intelliatx.com

    Unclassified inbox

    privacy@intelliatx.com

    Unclassified inbox

    abcdefghij@intelliatx.com

    Unclassified inbox

    lina.li@intelliatx.com

    Unclassified inbox

    info@intelliatx.com

    General Inquiries

    nmedia@intelliatx.com

    Media Relations

    jenn.smoter@intelliatx.com

    Unclassified inbox

    an.karp@intelliatx.com

    Unclassified inbox

    nlina.li@intelliatx.com

    Unclassified inbox

Similar Companies like Intellia Therapeutics

Moderna

modernatx.com
Biotechnology Β· Cambridge, MA Β· Est. 2010 Β· 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology Β· Bothell, Washington, United States Β· Est. 1998 Β· 1001–5000 employees Β· $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology Β· Cheshire, Connecticut, United States Β· Est. 1992 Β· 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology Β· Temple City, California, United States Β· Est. 2011 Β· 1001–5000 employees

HQ: Temple City, California, United States

Horizon Pharma

horizontherapeutics.com
Pharmaceuticals Β· Northbrook, Illinois, United States Β· Est. 2005 Β· 1001–5000 employees

HQ: Northbrook, Illinois, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 12/07/2025

(857) 285-6200

Cambridge, MA

Specialization: Genetics, Therapeutics,
Legal Name: Intellia Therapeutics, Inc.
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Founded Date: 2014
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NTLA
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: (857) 285-6200
Last Investment Activity: Mar 22, 2024
Investments Activity: Mar 22, 2024 Mar 6, 2024 Feb 22, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.